Angela Shen
Shenyang Agricultural University(CN)Ministry of Agriculture and Rural Affairs(CN)
Publications by Year
Research Areas
CAR-T cell therapy research, Protein Degradation and Inhibitors, Multiple Myeloma Research and Treatments, Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia(2014)5,325 cited
- → A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma(2017)1,724 cited
- → Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia(2015)1,707 cited
- → Panobinostat in Patients With Relapsed/Refractory Hodgkin's Lymphoma After Autologous Stem-Cell Transplantation: Results of a Phase II Study(2012)260 cited
- → The Infection Attack Rate and Severity of 2009 Pandemic H1N1 Influenza in Hong Kong(2010)192 cited
- → Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cells(2017)181 cited
- → BET protein proteolysis targeting chimera (PROTAC) exerts potent lethal activity against mantle cell lymphoma cells(2017)175 cited
- → Divergent medial amygdala projections regulate approach–avoidance conflict behavior(2019)122 cited
- → A phase I study of XL281, a selective oral RAF kinase inhibitor, in patients (Pts) with advanced solid tumors(2009)95 cited
- → A first-in-human phase I study to evaluate the MEK1/2 inhibitor, cobimetinib, administered daily in patients with advanced solid tumors(2016)83 cited